Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA
Supplementary Data
Supplementary Data
Files in this Data Supplement:
Supplementary Data
- Docx file
Supplementary Figure 1
- eps file
Supplementary Table 2
- docx file
Supplementary Table 3
- docx file